| Title : S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset - Pelz_2018_Eur.J.Immunol_48_498 |
| Author(s) : Pelz A , Schaffert H , Diallo R , Hiepe F , Meisel A , Kohler S |
| Ref : European Journal of Immunology , 48 :498 , 2018 |
| Abstract : Pelz_2018_Eur.J.Immunol_48_498 |
| ESTHER : Pelz_2018_Eur.J.Immunol_48_498 |
| PubMedSearch : Pelz_2018_Eur.J.Immunol_48_498 |
| PubMedID: 29205338 |
Pelz A, Schaffert H, Diallo R, Hiepe F, Meisel A, Kohler S (2018)
S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset
European Journal of Immunology
48 :498
Pelz A, Schaffert H, Diallo R, Hiepe F, Meisel A, Kohler S (2018)
European Journal of Immunology
48 :498